Thrombin Inhibitor Market

1 Study Coverage
    1.1 Thrombin Inhibitor Product Introduction
    1.2 Market by Type
        1.2.1 Global Thrombin Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Argatroban
        1.2.3 Activase
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Thrombin Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Specialist Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Thrombin Inhibitor Sales Estimates and Forecasts 2017-2028
    2.2 Global Thrombin Inhibitor Revenue Estimates and Forecasts 2017-2028
    2.3 Global Thrombin Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Thrombin Inhibitor Sales by Region
        2.4.1 Global Thrombin Inhibitor Sales by Region (2017-2022)
        2.4.2 Global Sales Thrombin Inhibitor by Region (2023-2028)
    2.5 Global Thrombin Inhibitor Revenue by Region
        2.5.1 Global Thrombin Inhibitor Revenue by Region (2017-2022)
        2.5.2 Global Thrombin Inhibitor Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Thrombin Inhibitor Sales by Manufacturers
        3.1.1 Global Top Thrombin Inhibitor Manufacturers by Sales (2017-2022)
        3.1.2 Global Thrombin Inhibitor Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thrombin Inhibitor in 2021
    3.2 Global Thrombin Inhibitor Revenue by Manufacturers
        3.2.1 Global Thrombin Inhibitor Revenue by Manufacturers (2017-2022)
        3.2.2 Global Thrombin Inhibitor Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Thrombin Inhibitor Revenue in 2021
    3.3 Global Thrombin Inhibitor Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Thrombin Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Thrombin Inhibitor Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Thrombin Inhibitor Sales by Type
        4.1.1 Global Thrombin Inhibitor Historical Sales by Type (2017-2022)
        4.1.2 Global Thrombin Inhibitor Forecasted Sales by Type (2023-2028)
        4.1.3 Global Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    4.2 Global Thrombin Inhibitor Revenue by Type
        4.2.1 Global Thrombin Inhibitor Historical Revenue by Type (2017-2022)
        4.2.2 Global Thrombin Inhibitor Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    4.3 Global Thrombin Inhibitor Price by Type
        4.3.1 Global Thrombin Inhibitor Price by Type (2017-2022)
        4.3.2 Global Thrombin Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Thrombin Inhibitor Sales by Application
        5.1.1 Global Thrombin Inhibitor Historical Sales by Application (2017-2022)
        5.1.2 Global Thrombin Inhibitor Forecasted Sales by Application (2023-2028)
        5.1.3 Global Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    5.2 Global Thrombin Inhibitor Revenue by Application
        5.2.1 Global Thrombin Inhibitor Historical Revenue by Application (2017-2022)
        5.2.2 Global Thrombin Inhibitor Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    5.3 Global Thrombin Inhibitor Price by Application
        5.3.1 Global Thrombin Inhibitor Price by Application (2017-2022)
        5.3.2 Global Thrombin Inhibitor Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Thrombin Inhibitor Market Size by Type
        6.1.1 North America Thrombin Inhibitor Sales by Type (2017-2028)
        6.1.2 North America Thrombin Inhibitor Revenue by Type (2017-2028)
    6.2 North America Thrombin Inhibitor Market Size by Application
        6.2.1 North America Thrombin Inhibitor Sales by Application (2017-2028)
        6.2.2 North America Thrombin Inhibitor Revenue by Application (2017-2028)
    6.3 North America Thrombin Inhibitor Market Size by Country
        6.3.1 North America Thrombin Inhibitor Sales by Country (2017-2028)
        6.3.2 North America Thrombin Inhibitor Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Thrombin Inhibitor Market Size by Type
        7.1.1 Europe Thrombin Inhibitor Sales by Type (2017-2028)
        7.1.2 Europe Thrombin Inhibitor Revenue by Type (2017-2028)
    7.2 Europe Thrombin Inhibitor Market Size by Application
        7.2.1 Europe Thrombin Inhibitor Sales by Application (2017-2028)
        7.2.2 Europe Thrombin Inhibitor Revenue by Application (2017-2028)
    7.3 Europe Thrombin Inhibitor Market Size by Country
        7.3.1 Europe Thrombin Inhibitor Sales by Country (2017-2028)
        7.3.2 Europe Thrombin Inhibitor Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Thrombin Inhibitor Market Size by Type
        8.1.1 Asia Pacific Thrombin Inhibitor Sales by Type (2017-2028)
        8.1.2 Asia Pacific Thrombin Inhibitor Revenue by Type (2017-2028)
    8.2 Asia Pacific Thrombin Inhibitor Market Size by Application
        8.2.1 Asia Pacific Thrombin Inhibitor Sales by Application (2017-2028)
        8.2.2 Asia Pacific Thrombin Inhibitor Revenue by Application (2017-2028)
    8.3 Asia Pacific Thrombin Inhibitor Market Size by Region
        8.3.1 Asia Pacific Thrombin Inhibitor Sales by Region (2017-2028)
        8.3.2 Asia Pacific Thrombin Inhibitor Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Thrombin Inhibitor Market Size by Type
        9.1.1 Latin America Thrombin Inhibitor Sales by Type (2017-2028)
        9.1.2 Latin America Thrombin Inhibitor Revenue by Type (2017-2028)
    9.2 Latin America Thrombin Inhibitor Market Size by Application
        9.2.1 Latin America Thrombin Inhibitor Sales by Application (2017-2028)
        9.2.2 Latin America Thrombin Inhibitor Revenue by Application (2017-2028)
    9.3 Latin America Thrombin Inhibitor Market Size by Country
        9.3.1 Latin America Thrombin Inhibitor Sales by Country (2017-2028)
        9.3.2 Latin America Thrombin Inhibitor Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Thrombin Inhibitor Market Size by Type
        10.1.1 Middle East and Africa Thrombin Inhibitor Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Thrombin Inhibitor Revenue by Type (2017-2028)
    10.2 Middle East and Africa Thrombin Inhibitor Market Size by Application
        10.2.1 Middle East and Africa Thrombin Inhibitor Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Thrombin Inhibitor Revenue by Application (2017-2028)
    10.3 Middle East and Africa Thrombin Inhibitor Market Size by Country
        10.3.1 Middle East and Africa Thrombin Inhibitor Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Thrombin Inhibitor Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Corporation Information
        11.1.2 Bristol-Myers Squibb Overview
        11.1.3 Bristol-Myers Squibb Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bristol-Myers Squibb Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Bayer
        11.2.1 Bayer Corporation Information
        11.2.2 Bayer Overview
        11.2.3 Bayer Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 Genentech
        11.4.1 Genentech Corporation Information
        11.4.2 Genentech Overview
        11.4.3 Genentech Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Genentech Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Genentech Recent Developments
    11.5 CSL
        11.5.1 CSL Corporation Information
        11.5.2 CSL Overview
        11.5.3 CSL Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CSL Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CSL Recent Developments
    11.6 Abbott
        11.6.1 Abbott Corporation Information
        11.6.2 Abbott Overview
        11.6.3 Abbott Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Abbott Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Abbott Recent Developments
    11.7 Armetheon
        11.7.1 Armetheon Corporation Information
        11.7.2 Armetheon Overview
        11.7.3 Armetheon Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Armetheon Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Armetheon Recent Developments
    11.8 Microbix Biosystems
        11.8.1 Microbix Biosystems Corporation Information
        11.8.2 Microbix Biosystems Overview
        11.8.3 Microbix Biosystems Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Microbix Biosystems Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Microbix Biosystems Recent Developments
    11.9 Astrazeneca
        11.9.1 Astrazeneca Corporation Information
        11.9.2 Astrazeneca Overview
        11.9.3 Astrazeneca Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Astrazeneca Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Astrazeneca Recent Developments
    11.10 Baxter
        11.10.1 Baxter Corporation Information
        11.10.2 Baxter Overview
        11.10.3 Baxter Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Baxter Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Baxter Recent Developments
    11.11 Emisphere Technologies
        11.11.1 Emisphere Technologies Corporation Information
        11.11.2 Emisphere Technologies Overview
        11.11.3 Emisphere Technologies Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Emisphere Technologies Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Emisphere Technologies Recent Developments
    11.12 Johnson & Johnson
        11.12.1 Johnson & Johnson Corporation Information
        11.12.2 Johnson & Johnson Overview
        11.12.3 Johnson & Johnson Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Johnson & Johnson Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Johnson & Johnson Recent Developments
    11.13 Merck
        11.13.1 Merck Corporation Information
        11.13.2 Merck Overview
        11.13.3 Merck Thrombin Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Merck Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Thrombin Inhibitor Industry Chain Analysis
    12.2 Thrombin Inhibitor Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Thrombin Inhibitor Production Mode & Process
    12.4 Thrombin Inhibitor Sales and Marketing
        12.4.1 Thrombin Inhibitor Sales Channels
        12.4.2 Thrombin Inhibitor Distributors
    12.5 Thrombin Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Thrombin Inhibitor Industry Trends
    13.2 Thrombin Inhibitor Market Drivers
    13.3 Thrombin Inhibitor Market Challenges
    13.4 Thrombin Inhibitor Market Restraints
14 Key Findings in The Global Thrombin Inhibitor Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Thrombin Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Argatroban
    Table 3. Major Manufacturers of Activase
    Table 4. Major Manufacturers of Others
    Table 5. Global Thrombin Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Thrombin Inhibitor Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Thrombin Inhibitor Sales by Region (2017-2022) & (K Pieces)
    Table 8. Global Thrombin Inhibitor Sales Market Share by Region (2017-2022)
    Table 9. Global Thrombin Inhibitor Sales by Region (2023-2028) & (K Pieces)
    Table 10. Global Thrombin Inhibitor Sales Market Share by Region (2023-2028)
    Table 11. Global Thrombin Inhibitor Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Thrombin Inhibitor Revenue Market Share by Region (2017-2022)
    Table 13. Global Thrombin Inhibitor Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Thrombin Inhibitor Revenue Market Share by Region (2023-2028)
    Table 15. Global Thrombin Inhibitor Sales by Manufacturers (2017-2022) & (K Pieces)
    Table 16. Global Thrombin Inhibitor Sales Share by Manufacturers (2017-2022)
    Table 17. Global Thrombin Inhibitor Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Thrombin Inhibitor Revenue Share by Manufacturers (2017-2022)
    Table 19. Thrombin Inhibitor Price by Manufacturers (2017-2022) &(USD/Piece)
    Table 20. Global Thrombin Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Thrombin Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin Inhibitor as of 2021)
    Table 22. Thrombin Inhibitor Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Thrombin Inhibitor Product Offered
    Table 24. Date of Manufacturers Enter into Thrombin Inhibitor Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 27. Global Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 28. Global Thrombin Inhibitor Sales Share by Type (2017-2022)
    Table 29. Global Thrombin Inhibitor Sales Share by Type (2023-2028)
    Table 30. Global Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Thrombin Inhibitor Revenue Share by Type (2017-2022)
    Table 33. Global Thrombin Inhibitor Revenue Share by Type (2023-2028)
    Table 34. Thrombin Inhibitor Price by Type (2017-2022) & (USD/Piece)
    Table 35. Global Thrombin Inhibitor Price Forecast by Type (2023-2028) & (USD/Piece)
    Table 36. Global Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 37. Global Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 38. Global Thrombin Inhibitor Sales Share by Application (2017-2022)
    Table 39. Global Thrombin Inhibitor Sales Share by Application (2023-2028)
    Table 40. Global Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Thrombin Inhibitor Revenue Share by Application (2017-2022)
    Table 43. Global Thrombin Inhibitor Revenue Share by Application (2023-2028)
    Table 44. Thrombin Inhibitor Price by Application (2017-2022) & (USD/Piece)
    Table 45. Global Thrombin Inhibitor Price Forecast by Application (2023-2028) & (USD/Piece)
    Table 46. North America Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 47. North America Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 48. North America Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 51. North America Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 52. North America Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Thrombin Inhibitor Sales by Country (2017-2022) & (K Pieces)
    Table 55. North America Thrombin Inhibitor Sales by Country (2023-2028) & (K Pieces)
    Table 56. North America Thrombin Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Thrombin Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 59. Europe Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 60. Europe Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 63. Europe Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 64. Europe Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Thrombin Inhibitor Sales by Country (2017-2022) & (K Pieces)
    Table 67. Europe Thrombin Inhibitor Sales by Country (2023-2028) & (K Pieces)
    Table 68. Europe Thrombin Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Thrombin Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 71. Asia Pacific Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 72. Asia Pacific Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 75. Asia Pacific Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 76. Asia Pacific Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Thrombin Inhibitor Sales by Region (2017-2022) & (K Pieces)
    Table 79. Asia Pacific Thrombin Inhibitor Sales by Region (2023-2028) & (K Pieces)
    Table 80. Asia Pacific Thrombin Inhibitor Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Thrombin Inhibitor Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 83. Latin America Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 84. Latin America Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 87. Latin America Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 88. Latin America Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Thrombin Inhibitor Sales by Country (2017-2022) & (K Pieces)
    Table 91. Latin America Thrombin Inhibitor Sales by Country (2023-2028) & (K Pieces)
    Table 92. Latin America Thrombin Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Thrombin Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Thrombin Inhibitor Sales by Type (2017-2022) & (K Pieces)
    Table 95. Middle East and Africa Thrombin Inhibitor Sales by Type (2023-2028) & (K Pieces)
    Table 96. Middle East and Africa Thrombin Inhibitor Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Thrombin Inhibitor Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Thrombin Inhibitor Sales by Application (2017-2022) & (K Pieces)
    Table 99. Middle East and Africa Thrombin Inhibitor Sales by Application (2023-2028) & (K Pieces)
    Table 100. Middle East and Africa Thrombin Inhibitor Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Thrombin Inhibitor Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Thrombin Inhibitor Sales by Country (2017-2022) & (K Pieces)
    Table 103. Middle East and Africa Thrombin Inhibitor Sales by Country (2023-2028) & (K Pieces)
    Table 104. Middle East and Africa Thrombin Inhibitor Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Thrombin Inhibitor Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bristol-Myers Squibb Corporation Information
    Table 107. Bristol-Myers Squibb Description and Major Businesses
    Table 108. Bristol-Myers Squibb Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 109. Bristol-Myers Squibb Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bristol-Myers Squibb Recent Developments
    Table 111. Bayer Corporation Information
    Table 112. Bayer Description and Major Businesses
    Table 113. Bayer Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 114. Bayer Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bayer Recent Developments
    Table 116. Sanofi Corporation Information
    Table 117. Sanofi Description and Major Businesses
    Table 118. Sanofi Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 119. Sanofi Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Sanofi Recent Developments
    Table 121. Genentech Corporation Information
    Table 122. Genentech Description and Major Businesses
    Table 123. Genentech Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 124. Genentech Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Genentech Recent Developments
    Table 126. CSL Corporation Information
    Table 127. CSL Description and Major Businesses
    Table 128. CSL Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 129. CSL Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. CSL Recent Developments
    Table 131. Abbott Corporation Information
    Table 132. Abbott Description and Major Businesses
    Table 133. Abbott Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 134. Abbott Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Abbott Recent Developments
    Table 136. Armetheon Corporation Information
    Table 137. Armetheon Description and Major Businesses
    Table 138. Armetheon Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 139. Armetheon Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Armetheon Recent Developments
    Table 141. Microbix Biosystems Corporation Information
    Table 142. Microbix Biosystems Description and Major Businesses
    Table 143. Microbix Biosystems Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 144. Microbix Biosystems Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Microbix Biosystems Recent Developments
    Table 146. Astrazeneca Corporation Information
    Table 147. Astrazeneca Description and Major Businesses
    Table 148. Astrazeneca Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 149. Astrazeneca Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Astrazeneca Recent Developments
    Table 151. Baxter Corporation Information
    Table 152. Baxter Description and Major Businesses
    Table 153. Baxter Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 154. Baxter Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Baxter Recent Developments
    Table 156. Emisphere Technologies Corporation Information
    Table 157. Emisphere Technologies Description and Major Businesses
    Table 158. Emisphere Technologies Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 159. Emisphere Technologies Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Emisphere Technologies Recent Developments
    Table 161. Johnson & Johnson Corporation Information
    Table 162. Johnson & Johnson Description and Major Businesses
    Table 163. Johnson & Johnson Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 164. Johnson & Johnson Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Johnson & Johnson Recent Developments
    Table 166. Merck Corporation Information
    Table 167. Merck Description and Major Businesses
    Table 168. Merck Thrombin Inhibitor Sales (K Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 169. Merck Thrombin Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Merck Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Thrombin Inhibitor Distributors List
    Table 174. Thrombin Inhibitor Customers List
    Table 175. Thrombin Inhibitor Market Trends
    Table 176. Thrombin Inhibitor Market Drivers
    Table 177. Thrombin Inhibitor Market Challenges
    Table 178. Thrombin Inhibitor Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Thrombin Inhibitor Product Picture
    Figure 3. Global Thrombin Inhibitor Market Share by Type in 2021 & 2028
    Figure 3. Argatroban Product Picture
    Figure 4. Activase Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Thrombin Inhibitor Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Specialist Clinic
    Figure 9. Others
    Figure 10. Thrombin Inhibitor Report Years Considered
    Figure 11. Global Thrombin Inhibitor Sales 2017-2028 (K Pieces)
    Figure 12. Global Thrombin Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Thrombin Inhibitor Revenue 2017-2028 (US$ Million)
    Figure 14. Global Thrombin Inhibitor Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Thrombin Inhibitor Sales Market Share by Region (2017-2022)
    Figure 16. Global Thrombin Inhibitor Sales Market Share by Region (2023-2028)
    Figure 17. North America Thrombin Inhibitor Sales YoY (2017-2028) & (K Pieces)
    Figure 18. North America Thrombin Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Thrombin Inhibitor Sales YoY (2017-2028) & (K Pieces)
    Figure 20. Europe Thrombin Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Thrombin Inhibitor Sales YoY (2017-2028) & (K Pieces)
    Figure 22. Asia-Pacific Thrombin Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Thrombin Inhibitor Sales YoY (2017-2028) & (K Pieces)
    Figure 24. Latin America Thrombin Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Thrombin Inhibitor Sales YoY (2017-2028) & (K Pieces)
    Figure 26. Middle East & Africa Thrombin Inhibitor Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Thrombin Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Thrombin Inhibitor in the World: Market Share by Thrombin Inhibitor Revenue in 2021
    Figure 29. Global Thrombin Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 31. Global Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 32. Global Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 33. Global Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 34. North America Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 35. North America Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 36. North America Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 37. North America Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 38. North America Thrombin Inhibitor Sales Share by Country (2017-2028)
    Figure 39. North America Thrombin Inhibitor Revenue Share by Country (2017-2028)
    Figure 40. U.S. Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 43. Europe Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 45. Europe Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Thrombin Inhibitor Sales Share by Country (2017-2028)
    Figure 47. Europe Thrombin Inhibitor Revenue Share by Country (2017-2028)
    Figure 48. Germany Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 49. France Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Thrombin Inhibitor Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Thrombin Inhibitor Revenue Share by Region (2017-2028)
    Figure 59. China Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 62. India Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Thrombin Inhibitor Sales Share by Country (2017-2028)
    Figure 74. Latin America Thrombin Inhibitor Revenue Share by Country (2017-2028)
    Figure 75. Mexico Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Thrombin Inhibitor Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Thrombin Inhibitor Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Thrombin Inhibitor Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Thrombin Inhibitor Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Thrombin Inhibitor Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Thrombin Inhibitor Revenue Share by Country (2017-2028)
    Figure 84. Turkey Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Thrombin Inhibitor Revenue (2017-2028) & (US$ Million)
    Figure 87. Thrombin Inhibitor Value Chain
    Figure 88. Thrombin Inhibitor Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed